February 5, 2015—The Health Resources and Services Administration today identified 13 drug companies that are not complying with its 340B orphan drug exclusion interpretive rule. … [Read more...]
Archives for February 2015
President Seeks $24.73 Million for 340B Oversight and Operations
Patient definition and hospital eligibility guidance "to be finalized" in fiscal year 2016February 2, 2015—The Obama administration is seeking $24.73 million to run the 340B drug discount program in the fiscal year that begins in October – more than double this year's funding level. The request came in the proposed fiscal year 2016 budget that the President sent to Congress today. … [Read more...]
Reducing or Eliminating 340B “Could Cripple Safety Net”
At a time when Medicaid and Medicare reimbursement rates continue to shrink, reducing or eliminating 340B could cripple safety net providers across the U.S., the president of the Institute for Healthcare Innovation writes today in Healthcare Finance. "Without a strong and vibrant 340B program, safety net providers may not be able to afford high-priced medications developed by … [Read more...]